Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 56,300 | 28,200 | 124,700 | 92,700 | 65,700 |
| Depreciation Amortization | 46,600 | 23,100 | 87,200 | 64,500 | 44,200 |
| Other Working Capital | -19,500 | -9,100 | -22,200 | -34,900 | -28,300 |
| Other Operating Activity | 2,100 | -7,100 | -37,400 | -8,600 | -11,300 |
| Operating Cash Flow | $85,500 | $35,100 | $152,300 | $113,700 | $70,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -37,600 | -17,800 | -103,800 | -77,000 | -49,700 |
| Net Acquisitions | -4,000 | -4,000 | -47,900 | -64,700 | -9,000 |
| Other Investing Activity | 8,000 | 5,700 | 4,800 | 4,300 | 4,100 |
| Investing Cash Flow | $-33,600 | $-16,100 | $-146,900 | $-137,400 | $-54,600 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -24,900 | -10,100 | -10,500 | 47,200 | 2,300 |
| Financing Cash Flow | $-24,900 | $-10,100 | $-10,500 | $47,200 | $2,300 |
| Exchange Rate Effect | -1,000 | 100 | 400 | 200 | 0 |
| Beginning Cash Position | 1,700 | 1,700 | 6,400 | 6,400 | 6,400 |
| End Cash Position | 27,700 | 10,700 | 1,700 | 30,100 | 24,400 |
| Net Cash Flow | $26,000 | $9,000 | $-4,700 | $23,700 | $18,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 85,500 | 35,100 | 152,300 | 113,700 | 70,300 |
| Free Cash Flow | 85,500 | 35,100 | 152,300 | 113,700 | 70,300 |